Skip to main content

Published locations for Gilteritinib shows safety, efficacy in relapsed/refractory AML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Gilteritinib shows safety, efficacy in relapsed/refractory AML

User login

  • Reset your password
  • /content/gilteritinib-shows-safety-efficacy-relapsed/refractory-aml
  • /hematologynews/article/141165/aml/gilteritinib-shows-safety-efficacy-relapsed/refractory-aml
  • /oncologypractice/article/141165/aml/gilteritinib-shows-safety-efficacy-relapsed/refractory-aml
  • /hematology-oncology/article/141165/aml/gilteritinib-shows-safety-efficacy-relapsed/refractory-aml